Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPEED: Tropicamide-Phenylephrine Dosing Regimens for Pupil Dilation
NCT04907474Phase 4Completed
- Sponsor
- Hyperion DeFi
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of phenylephrine + tropicamide in Mydriasis, sponsored by Hyperion DeFi. Started May 2021; status: completed.
02
Drugs
phenylephrine + tropicamide
03
Conditions
Mydriasis
Beyond the preview
Go deeper on NCT04907474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04907474.